戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1      Women were enrolled at </=20 wk of gestation; children were assessed at 12 (n = 3331), 18 (n = 3364), and 24 (n = 33
2                        Two hundred fifty-four (83%) infants were assessed at 12 months of age.
3                                             All 14 patients were assessed at 12 months.
4   Behavioral phenotypes related to cognition and depression were assessed at 15 and 24 months, and brain pathology and bi
5                                                 11 patients were assessed at 18 months.
6     There were no dropouts in this group and all 3 patients were assessed at 18 months.
7 ruited) and 183 term-born controls (91.0% of 201 recruited) were assessed at 2 years' corrected age.
8 d at 15 and 24 months, and brain pathology and biochemistry were assessed at 24 months.
9 ionnaire score, and modified Medical Research Council score were assessed at 3 and 6 months, and target lobe volume reduc
10                                               Safety events were assessed at 3 months.
11                               Cognitive and motor abilities were assessed at 3 years, corrected age.
12                                                Participants were assessed at 3-6 time points, ranging from age 3 months t
13 on, executive function, visual function, and motor function were assessed at 4.5 years.
14                                 Anxiety and risk perception were assessed at 6 weeks and 1 year.
15 e changes in PD, CAL, and percentage of bone fill, and they were assessed at 6, 9, and 12 months.
16                                            Primary outcomes were assessed at a P value of 0.05 or less, and secondary out
17 , Working Memory, and Processing Speed (secondary outcomes) were assessed at age 38 years using the Wechsler Adult Intell
18  Chinese schoolchildren, fish consumption and sleep quality were assessed at age 9-11 years, while IQ was assessed at age
19 revalence and determinants of genotype-specific concordance were assessed at annual visits.
20     Clinical scores and autobiographical memory performance were assessed at baseline and 1 week after the final rtfMRI-n
21 n A-I, cholesterol efflux capacity, and HDL particle number were assessed at baseline and 12 months in a nested case-cont
22  20 years enrolled in the Inherited Neuropathies Consortium were assessed at baseline and 2 years.
23                Iron markers, fecal pH, and bacterial groups were assessed at baseline and 3 wk.
24                                          Metabolic profiles were assessed at baseline and after 3 months of treatment.
25                                               PTSD symptoms were assessed at baseline and approximately 1, 3, 6, and 12 m
26                   Fifty-five children (2 to 7 years of age) were assessed at baseline and at 12 months and grouped as car
27                                                      Youths were assessed at baseline and at four 6-month intervals with
28 ance imaging responses during an N-back working memory task were assessed at baseline and at the end of treatment.
29           Clinical, functional, and inflammatory parameters were assessed at baseline and at yearly visits.
30     Participant demographics, drug use, and risk behaviours were assessed at baseline and every 3 months using an audio c
31 pha (8-isoPGF2alpha), and epigenetic regulation of p66(Shc) were assessed at baseline and follow-up.
32       Anthropometric, metabolic, and periodontal parameters were assessed at baseline and re-evaluated at 3 and 6 months.
33                                                Participants were assessed at baseline and were followed up at 3, 6, and 9
34 e material (SHRM), and pigment epithelial detachment (PED), were assessed at baseline to determine whether they influence
35                                                    Outcomes were assessed at baseline, after treatment, and at 6-month fo
36                     Clinical and echocardiographic outcomes were assessed at baseline, discharge, and 30 days.
37                            As an exploratory endpoint, PROs were assessed at baseline, week 9, and every 6 weeks thereaft
38                                             Antibody levels were assessed at birth, day (D) 43, and D91 for GBS serotypes
39 erpretability, effective dose (ED), and diagnostic accuracy were assessed at CT angiography and were compared with those
40                                                        PROs were assessed at day 1 of cycles 1-3, every 9 weeks thereafte
41              The cumulative incidence rates of sudden death were assessed at different time points after randomization an
42                                The mental health indicators were assessed at home visits done between May 12, 2011, and M
43 al and post acute kidney injury chronic dialysis dependency were assessed at hospital discharge according to the quintile
44                                                        They were assessed at least six times with the CRS-R within a 10-d
45                                 bREC and probing parameters were assessed at presurgery and 6 months post-surgery.
46               Receipt of SSA benefits and clinical outcomes were assessed at program entry and every 6 months for 2 years
47                                                        VRCs were assessed at rest, during 30 min of induced limb ischaemi
48                        Clinical and radiographic parameters were assessed at site level and analyzed for possible associa
49                                                     Effects were assessed at the intra-lineage level (within human-associ
50                                        Seventy-six patients were assessed at their first spontaneous breathing trial: 63%

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。
 
コーパス検索結果について
ご利用ガイド
ご利用規定
新規対訳・お問い合わせ
Copyright 1993 - ライフサイエンス辞書プロジェクト